Cpb2 (carboxypeptidase B2) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Cpb2 (carboxypeptidase B2) Rattus norvegicus
Symbol: Cpb2
Name: carboxypeptidase B2
RGD ID: 71035
Description: Enables carboxypeptidase activity. Involved in several processes, including liver regeneration; negative regulation of hepatocyte proliferation; and regulation of blood coagulation. Located in extracellular space. Human ortholog(s) of this gene implicated in chronic kidney disease. Orthologous to human CPB2 (carboxypeptidase B2); PARTICIPATES IN fibrinolysis pathway; coagulation cascade pathway; complement system pathway; INTERACTS WITH (+)-schisandrin B; 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: carboxypeptidase B2 (plasma); carboxypeptidase R; carboxypeptidase U; CPR; CPU; LOC684726; similar to carboxypeptidase B2 (plasma); TAFI; thrombin-activable fibrinolysis inhibitor
RGD Orthologs
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.21550,557,722 - 50,606,569 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1550,557,717 - 50,606,556 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1554,699,866 - 54,748,774 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01555,818,184 - 55,867,090 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01552,650,058 - 52,698,853 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01557,290,849 - 57,339,762 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1557,290,849 - 57,339,760 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01561,001,889 - 61,050,732 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41556,104,920 - 56,154,321 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11556,120,686 - 56,170,027 (+)NCBI
Celera1550,189,675 - 50,237,544 (+)NCBICelera
Cytogenetic Map15q11NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Molecular Function

Molecular Pathway Annotations     Click to see Annotation Detail View

References - curated
# Reference Title Reference Citation
1. Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor. Aso Y, etal., Diabetes Care. 2005 Sep;28(9):2211-6.
2. An inhibitor of thrombin activated fibrinolysis inhibitor (TAFI) can reduce extracellular matrix accumulation in an in vitro model of glucose induced ECM expansion. Atkinson JM, etal., Matrix Biol. 2013 Jan 29. pii: S0945-053X(13)00007-3. doi: 10.1016/j.matbio.2013.01.006.
3. Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy-associated tubulointerstitial fibrosis. Bruno NE, etal., J Thromb Haemost. 2008 Jan;6(1):139-46. Epub 2007 Nov 5.
4. Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency. Bruno NE, etal., Thromb Haemost. 2008 Jul;100(1):90-100. doi: 10.1160/TH08-02-0092.
5. Thrombin activatable fibrinolysis inhibitor in Behcet's disease. Donmez A, etal., Thromb Res. 2005;115(4):287-92.
6. Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism. Eichinger S, etal., Blood. 2004 May 15;103(10):3773-6. Epub 2004 Jan 22.
7. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
8. Enhancement of endogenous plasminogen activator-induced thrombolysis by argatroban and APC and its control by TAFI, measured in an arterial thrombolysis model in vivo using rat mesenteric arterioles. Hashimoto M, etal., Thromb Haemost 2002 Jan;87(1):110-3.
9. Characterization of rat thrombin-activatable fibrinolysis inhibitor (TAFI)--a comparative study assessing the biological equivalence of rat, murine and human TAFI. Hillmayer K, etal., J Thromb Haemost. 2006 Nov;4(11):2470-7. Epub 2006 Sep 21.
10. Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients. Hori Y, etal., J Clin Endocrinol Metab. 2002 Feb;87(2):660-5.
11. Plasma levels of thrombin-activatable fibrinolysis inhibitor in primary and secondary thrombocytosis. Kaftan O, etal., Clin Appl Thromb Hemost. 2005 Oct;11(4):449-54.
12. Molecular cloning and partial characterization of rat procarboxypeptidase R and carboxypeptidase N. Kato T, etal., Microbiol Immunol 2000;44(8):719-28.
13. A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease. Kremer Hovinga JA, etal., J Thromb Haemost. 2004 Jan;2(1):54-7.
14. Basic mechanisms and regulation of fibrinolysis. Longstaff C and Kolev K, J Thromb Haemost. 2015 Jun;13 Suppl 1:S98-105. doi: 10.1111/jth.12935.
15. Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome. Malyszko J, etal., Blood Coagul Fibrinolysis. 2002 Oct;13(7):615-21.
16. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy. Malyszko J, etal., Thromb Haemost. 2004 Mar;91(3):480-6.
17. Gene Data Set MGD Curation, June 12, 2002
18. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
19. Association between TAFI antigen and Ala147Thr polymorphism of the TAFI gene and the angina pectoris incidence. The PRIME Study (Prospective Epidemiological Study of MI). Morange PE, etal., Thromb Haemost. 2003 Mar;89(3):554-60.
20. EF6265, a novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor, protects against sepsis-induced organ dysfunction in rats. Muto Y, etal., Crit Care Med. 2009 May;37(5):1744-9. doi: 10.1097/CCM.0b013e31819ffc14.
21. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
22. A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary culture. Okumura N, etal., J Biol Chem. 2009 Jun 12;284(24):16553-61. doi: 10.1074/jbc.M109.011452. Epub 2009 Apr 22.
23. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
24. Tissue factor pathway inhibitor and thrombin activatable fibrinolytic inhibitor plasma levels following burn and septic injuries in rats. Ravindranath TM, etal., Clin Appl Thromb Hemost. 2004 Oct;10(4):379-85.
25. Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsis. Ravindranath TM, etal., Clin Appl Thromb Hemost. 2007 Oct;13(4):362-8.
26. GOA pipeline RGD automated data pipeline
27. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
28. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
29. Minocycline effects on the cerebrospinal fluid proteome of experimental autoimmune encephalomyelitis rats. Stoop MP, etal., J Proteome Res. 2012 Aug 3;11(8):4315-25. doi: 10.1021/pr300428e. Epub 2012 Jul 25.
30. Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study. Sucker C, etal., Nephrol Dial Transplant. 2007 May;22(5):1347-50. Epub 2007 Feb 27.
31. Genetic variation in thrombin-activatable fibrinolysis inhibitor is associated with the risk of diabetic nephropathy. Xu CW, etal., J Endocrinol Invest. 2012 Jul;35(7):620-4.
32. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria. Yano Y, etal., J Clin Endocrinol Metab. 2003 Feb;88(2):736-41.
33. Association of a polymorphism of the apolipoprotein E gene with chronic kidney disease in Japanese individuals with metabolic syndrome. Yoshida T, etal., Genomics. 2009 Mar;93(3):221-6. doi: 10.1016/j.ygeno.2008.11.001. Epub 2008 Dec 6.
Additional References at PubMed
PMID:10739389   PMID:12477932   PMID:12958609   PMID:18513211   PMID:23533145   PMID:24188431   PMID:28289017  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.21550,557,722 - 50,606,569 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1550,557,717 - 50,606,556 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1554,699,866 - 54,748,774 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01555,818,184 - 55,867,090 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01552,650,058 - 52,698,853 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01557,290,849 - 57,339,762 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1557,290,849 - 57,339,760 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01561,001,889 - 61,050,732 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41556,104,920 - 56,154,321 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11556,120,686 - 56,170,027 (+)NCBI
Celera1550,189,675 - 50,237,544 (+)NCBICelera
Cytogenetic Map15q11NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh381346,053,186 - 46,105,033 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1346,053,186 - 46,105,033 (-)EnsemblGRCh38hg38GRCh38
GRCh371346,627,321 - 46,679,168 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 361345,525,323 - 45,577,212 (-)NCBINCBI36Build 36hg18NCBI36
Build 341345,525,322 - 45,577,169NCBI
Celera1327,682,037 - 27,734,241 (-)NCBICelera
Cytogenetic Map13q14.13NCBI
HuRef1327,424,287 - 27,477,016 (-)NCBIHuRef
CHM1_11346,596,461 - 46,648,341 (-)NCBICHM1_1
T2T-CHM13v2.01345,274,576 - 45,326,411 (-)NCBIT2T-CHM13v2.0
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm391475,479,727 - 75,520,995 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1475,479,727 - 75,520,995 (+)EnsemblGRCm39 Ensembl
GRCm381475,242,287 - 75,283,555 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1475,242,287 - 75,283,555 (+)EnsemblGRCm38mm10GRCm38
MGSCv371475,642,094 - 75,683,362 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv361473,976,443 - 74,017,701 (+)NCBIMGSCv36mm8
Celera1472,744,408 - 72,785,554 (+)NCBICelera
Cytogenetic Map14D3NCBI
cM Map1439.73NCBI
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
ChiLan1.0 EnsemblNW_0049555183,740,348 - 3,803,539 (-)EnsemblChiLan1.0
ChiLan1.0NW_0049555183,740,348 - 3,803,540 (-)NCBIChiLan1.0ChiLan1.0
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
NHGRI_mPanPan11336,339,651 - 36,393,445 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v01326,926,788 - 26,979,767 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
CanFam3.1225,074,805 - 5,126,635 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl225,074,816 - 5,126,170 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha225,060,946 - 5,113,389 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0225,190,115 - 5,242,228 (+)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl225,190,159 - 5,241,792 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1224,972,456 - 5,024,301 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0225,035,678 - 5,087,765 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0225,040,873 - 5,092,730 (+)NCBIUU_Cfam_GSD_1.0
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
HiC_Itri_2NW_024404945156,155,086 - 156,203,983 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_004936857577,585 - 626,267 (-)EnsemblSpeTri2.0
SpeTri2.0NW_004936857577,067 - 609,855 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
Sscrofa11.1 Ensembl1121,234,447 - 21,298,241 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11121,234,447 - 21,298,250 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21121,696,077 - 21,757,686 (+)NCBISscrofa10.2Sscrofa10.2susScr3
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
ChlSab1.1324,108,854 - 24,161,669 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl324,109,416 - 24,161,408 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366605719,855,294 - 19,907,245 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
HetGla_female_1.0 EnsemblNW_0046247488,849,900 - 8,928,853 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046247488,850,128 - 8,927,986 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2


Variants in Cpb2
276 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:145
Count of miRNA genes:106
Interacting mature miRNAs:112
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
2298549Neuinf12Neuroinflammation QTL 123.5nervous system integrity trait (VT:0010566)spinal cord beta-2 microglobulin mRNA level (CMO:0002125)15155302115Rat
631273Lecl2Lens clarity QTL 20.001lens clarity trait (VT:0001304)age of onset/diagnosis of cataract (CMO:0001584)151059608955596089Rat
2300167Bmd63Bone mineral density QTL 635.90.0001femur mineral mass (VT:0010011)volumetric bone mineral density (CMO:0001553)151111114256111142Rat
2300173Bmd62Bone mineral density QTL 6212.80.0001lumbar vertebra mineral mass (VT:0010511)volumetric bone mineral density (CMO:0001553)151111114256111142Rat
2293688Bss29Bone structure and strength QTL 295.310.0001femur morphology trait (VT:0000559)femur midshaft cortical cross-sectional area (CMO:0001663)151111114256111142Rat
2317750Glom26Glomerulus QTL 264.3urine protein amount (VT:0005160)urine protein level (CMO:0000591)151249614165205939Rat
61424Scl1Serum cholesterol level QTL 17.70.001blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)151672552880672115Rat
1331729Rf42Renal function QTL 423.071kidney blood vessel physiology trait (VT:0100012)absolute change in renal blood flow rate (CMO:0001168)151736289773690657Rat
10054130Srcrt8Stress Responsive Cort QTL 82.180.0085blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)152211793367117933Rat
1578646Bmd18Bone mineral density QTL 185.2femur mineral mass (VT:0010011)trabecular volumetric bone mineral density (CMO:0001729)152280624098288169Rat
1578647Bmd17Bone mineral density QTL 174femur mineral mass (VT:0010011)total volumetric bone mineral density (CMO:0001728)152280624098288169Rat
1578660Bss19Bone structure and strength QTL 194.3femur morphology trait (VT:0000559)bone trabecular cross-sectional area (CMO:0002311)152280624098288169Rat
1582214Stl21Serum triglyceride level QTL 213.10.022blood triglyceride amount (VT:0002644)serum triglyceride level (CMO:0000360)152803066582262678Rat
1582227Gluco30Glucose level QTL 303.60.0003blood glucose amount (VT:0000188)absolute change in blood glucose level area under curve (CMO:0002034)152803066582262678Rat
1582228Epfw3Epididymal fat weight QTL 34.10.0002epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)152803066582262678Rat
1582242Gluco28Glucose level QTL 283.30.0008blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)152803066582262678Rat
1582244Bw79Body weight QTL 7940.0002epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)152803066582262678Rat
2293691Bmd37Bone mineral density QTL 376.60.0001femur strength trait (VT:0010010)femur total energy absorbed before break (CMO:0001677)153361105871477291Rat
2293686Bmd36Bone mineral density QTL 367.40.0001femur strength trait (VT:0010010)femoral neck ultimate force (CMO:0001703)153361105871477291Rat
1598828Glom14Glomerulus QTL 142.5kidney glomerulus morphology trait (VT:0005325)index of glomerular damage (CMO:0001135)153405413979054139Rat
1300144Rf23Renal function QTL 233.61renal blood flow trait (VT:2000006)absolute change in renal vascular resistance (CMO:0001900)154063126898288169Rat


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
Medium 41 41 41 1
Low 3 3 9 6 2 2 4 3 14 9 2
Below cutoff 6 7 12 6 7 28 23 20 1 6


RefSeq Acc Id: ENSRNOT00000014909   ⟹   ENSRNOP00000014909
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1550,557,717 - 50,606,556 (+)Ensembl
Rnor_6.0 Ensembl1557,290,849 - 57,339,760 (+)Ensembl
RefSeq Acc Id: NM_053617   ⟹   NP_446069
RefSeq Status: VALIDATED
Rat AssemblyChrPosition (strand)Source
mRatBN7.21550,557,722 - 50,606,563 (+)NCBI
Rnor_6.01557,290,849 - 57,339,762 (+)NCBI
Rnor_5.01561,001,889 - 61,050,732 (+)NCBI
RGSC_v3.41556,104,920 - 56,154,321 (+)RGD
Celera1550,189,675 - 50,237,544 (+)NCBI
RefSeq Acc Id: XM_039092945   ⟹   XP_038948873
Rat AssemblyChrPosition (strand)Source
mRatBN7.21550,557,737 - 50,606,569 (+)NCBI
RefSeq Acc Id: NP_446069   ⟸   NM_053617
- Peptide Label: precursor
- UniProtKB: Q3B7V3 (UniProtKB/Swiss-Prot),   Q5BKB8 (UniProtKB/Swiss-Prot),   Q9EQV9 (UniProtKB/Swiss-Prot),   A6HTS6 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000014909   ⟸   ENSRNOT00000014909
RefSeq Acc Id: XP_038948873   ⟸   XM_039092945
- Peptide Label: isoform X1

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-Q9EQV9-F1-model_v2 AlphaFold Q9EQV9 1-422 view protein structure


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:71035 AgrOrtholog
BioCyc Gene G2FUF-13131 BioCyc
Ensembl Genes ENSRNOG00000010935 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Protein ENSRNOP00000014909 ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENSRNOT00000014909 ENTREZGENE, UniProtKB/Swiss-Prot
Gene3D-CATH UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Zn peptidases UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
InterPro CPB2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  M14A-like_propep UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  M14A_act_pep UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Peptidase_M14 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:113936 UniProtKB/Swiss-Prot
Pfam Peptidase_M14 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Propep_M14 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PhenoGen Cpb2 PhenoGen
SMART Zn_pept UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP Protease propeptides/inhibitors UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Zn-dependent exopeptidases UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  CBPB2_RAT UniProtKB/Swiss-Prot
UniProt Secondary Q3B7V3 UniProtKB/Swiss-Prot
  Q5BKB8 UniProtKB/Swiss-Prot

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2015-12-23 Cpb2  carboxypeptidase B2  Cpb2  carboxypeptidase B2 (plasma)  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2013-04-17 Cpb2  carboxypeptidase B2 (plasma)  LOC684726  similar to carboxypeptidase B2 (plasma)  Data Merged 737654 PROVISIONAL
2006-11-19 LOC684726  similar to carboxypeptidase B2 (plasma)      Symbol and Name status set to provisional 70820 PROVISIONAL
2002-07-09 Cpb2  carboxypeptidase B2 (plasma)      Symbol and Name updated to reflect Human and Mouse nomenclature 70877 APPROVED

RGD Curation Notes
Note Type Note Reference